Catch up with the most viewed articles from Frontiers in Oncology this May. All are Open Access – enjoy!
Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pinterest (Opens in new window)MoreClick to share on WhatsApp (Opens in new window)Click to email a link to a friend (Opens in new window)
Like this:Like Loading…
SBRT: an opportunity to improve quality of life for oligometastatic prostate cancer Gregory Azzam*, Rachelle Lanciano*, Steve Arrigo, John Lamond, Billy Ding, Jun Yang, Alexandra Hanlon, Michael Good, and Luther Brady
Downregulation of MYCN through PI3K inhibition in mouse models of pediatric neural cancer Tene Aneka Cage, Yvan Chanthery, Louis Chesler, Matthew Grimmer, Zachary Knight, Kevan Shokat, William A Weiss, and W. Clay Gustafson*
Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastases Daniel Gorovets*, Paul Rava, Daniel K Ebner, David J Tybor, Deus Cielo, Yakub Puthawala, Timothy J Kinsella, Thomas A DiPetrillo, David E Wazer, and Jaroslaw T Hepel
Trends and characteristics of young non-small cell lung cancer patients in the United States Anish Thomas, Yuanbin Chen, Tinghui Yu, Marko Jakopovic, and Giuseppe Giaccone*
Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation Laia Gorchs, Turid Hellevik, Jack-Ansgar Bruun, Ketil-Andre Camilio, Samer Al-Saad, Tor-Brynjar Stuge, and Inigo Martinez-Zubiaurre*
Phosphoproteomic analysis of cell-based resistance to BRAF inhibitor therapy in melanoma Robert Parker, Laura Vella, Dylan Xavier, Ardeshir Amirkhani, Jimmy Parker, Jonathan Cebon, and Mark Molloy*
Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and I125 vicryl mesh brachytherapy Beant Singh Gill, David Anthony Clump, Steven A Burton, Neil A Christie, Matthew J Schuchert, and Dwight E Heron*
Pazopanib-induced alopecia, an underestimated toxicity? Andrea Biondo, Helen Alexander, Komel Khabra, Lisa Pickering, Martin Gore, and James Larkin*
Spot weight adaptation for moving target in spot scanning proton therapy Paul Morel, Xiaodong Wu, Guillaume Blin, Stéphane Vialette, Ryan Flynn, Daniel Hyer, and Dongxu Wang*
Salvage fractionated stereotactic radiotherapy with or without chemotherapy and immunotherapy for recurrent glioblastoma multiforme: a single institution experience Shaakir Hasan*, Eda Chen, Rachelle Lanciano, Jun Yang, Alex Hanlon, John Lamond, Stephen Arrigo, William Ding, Michael Mikhail, Arezoo Ghaneie, and Luther Brady
